Rapport Therapeutics (RAPP) Non-cash Items (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Non-cash Items data on file, last reported at $2.5 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $2.5 million, up 169.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 169.52% YoY), and the FY2025 annual result was $2.0 million, up 337.33% from the prior year.
• Non-cash Items eased to $2.5 million in Q1 2026 per RAPP's latest filing, from $113.8 million in the prior quarter.
• Over five years, Non-cash Items peaked at $113.8 million in Q4 2025 and troughed at $7662.0 in Q2 2024.
• A 4-year average of $35.2 million and a median of $6.2 million in 2023 frame the typical range for Non-cash Items.
• On a YoY basis, Non-cash Items climbed as much as 18662.56% in 2025 and fell as far as 149.77% in 2025.
• A 4-year view of Non-cash Items shows it stood at $6.2 million in 2023, then jumped by 449.27% to $34.3 million in 2024, then surged by 231.66% to $113.8 million in 2025, then slumped by 97.84% to $2.5 million in 2026.
• Business Quant data shows RAPP's Non-cash Items at $2.5 million in Q1 2026, $113.8 million in Q4 2025, and $112.4 million in Q3 2025.